|
|
|
Insider
Information: |
Celentano John E |
Relationship: |
Director |
City: |
Plainsboro |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
163,142 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,728,424 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
163,142 |
|
|
Total
Value |
$5,728,424 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
SVP HR Public Affairs ... |
2012-03-06 |
142,142 |
2011-05-10 |
0 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-02-17 |
1,000 |
2009-02-17 |
0 |
Premium* |
|
Teligent Inc |
TLGT |
Director |
2019-05-31 |
20,000 |
2019-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
Pres Emerging Mkts & Asia-Pac |
|
2009-02-19 |
4/A |
D |
$20.51 |
$97,915 |
D/D |
(4,774) |
64,391 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Strat & Productivity Trans |
|
2009-03-01 |
4 |
D |
$18.41 |
$7,935 |
D/D |
(431) |
68,734 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Strat & Productivity Trans |
|
2009-03-02 |
4 |
D |
$17.74 |
$9,704 |
D/D |
(547) |
68,187 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres Emerging Mkts & Asia-Pac |
|
2009-03-06 |
4 |
D |
$18.35 |
$18,258 |
D/D |
(995) |
67,192 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres Emerging Mkts & Asia-Pac |
|
2009-12-04 |
4 |
D |
$25.14 |
$66,244 |
D/D |
(2,635) |
59,783 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres Emerging Mkts & Asia-Pac |
|
2010-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,174) |
63,336 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres Emerging Mkts & Asia-Pac |
|
2010-03-06 |
4 |
D |
$24.60 |
$30,922 |
D/D |
(1,257) |
66,335 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres Emerging Mkts & Asia-Pac |
|
2010-03-07 |
4 |
D |
$24.60 |
$24,452 |
D/D |
(994) |
65,341 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2010-12-06 |
4 |
D |
$25.89 |
$68,220 |
D/D |
(2,635) |
78,586 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2011-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,114) |
108,444 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2011-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,432) |
110,634 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2011-03-04 |
4 |
D |
$26.43 |
$27,804 |
D/D |
(1,052) |
112,242 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2011-03-06 |
4 |
D |
$26.43 |
$44,482 |
D/D |
(1,683) |
114,816 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2011-03-07 |
4 |
D |
$26.31 |
$35,019 |
D/D |
(1,331) |
113,485 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2011-05-12 |
4 |
D |
$28.63 |
$3,344,188 |
D/D |
(116,790) |
110,850 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2012-03-01 |
4 |
D |
$32.64 |
$39,690 |
D/D |
(1,216) |
113,752 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2012-03-02 |
4 |
D |
$32.59 |
$44,420 |
D/D |
(1,363) |
117,004 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2012-03-03 |
4 |
D |
$32.59 |
$28,484 |
D/D |
(874) |
119,090 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2012-03-04 |
4 |
D |
$32.59 |
$25,616 |
D/D |
(786) |
120,964 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP HR Public Affairs & Philan |
|
2012-03-06 |
4 |
D |
$32.33 |
$360,544 |
D/D |
(11,152) |
142,142 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
officerTitle |
|
2005-11-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,388 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
officerTitle |
|
2005-11-30 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,388 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
officerTitle |
|
2005-11-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,694 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
President, Health Care Group |
|
2007-05-11 |
4 |
OE |
$28.90 |
$455,146 |
D/D |
15,749 |
74,314 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
President, Health Care Group |
|
2007-05-15 |
4 |
OE |
$28.90 |
$130,079 |
D/D |
4,501 |
63,556 |
0 |
- |
|
70 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|